Product Information
SIROLIMUS 0.5 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $1.1138 per EA under NDC 68462068201. Its NADAC has been published 294 times since Nov 11, 2020.
Strength
.5 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462068201
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SIROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA208691On Market Since
10/16/2020
Pharmacological Classes
Price Statistics
The NADAC for SIROLIMUS 0.5 MG TABLET has been published 294 times since Nov 11, 2020, and over the history we have for it it has declined 79.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1138 per EA |
|---|---|
| All-time high | $5.9857 (Jan 13, 2021) |
| All-time low | $1.0918 (May 20, 2026) |
| 52-week high | $2.3742 |
| 52-week low | $1.0918 |
| Median price | $2.8962 |
| Average price | $3.4457 |
| Largest weekly change | -50.5% (Sep 20, 2023) |
| Weeks tracked | 294 |
| Tracking since | Nov 11, 2020 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SIROLIMUS 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SIROLIMUS 0.5 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $1.1138 per EA (NDC 68462068201), effective Jun 24, 2026.
How has the price of SIROLIMUS 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for SIROLIMUS 0.5 MG TABLET has declined 79.4%. It has been tracked across 294 weekly CMS publications since Nov 11, 2020.
What are the highest and lowest recorded NADAC prices for SIROLIMUS 0.5 MG TABLET?
Since Nov 11, 2020, the NADAC for SIROLIMUS 0.5 MG TABLET has ranged from a low of $1.0918 (May 20, 2026) to a high of $5.9857 (Jan 13, 2021), with a median of $2.8962 per EA.
Are there cheaper alternatives to SIROLIMUS 0.5 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as SIROLIMUS 0.5 MG TABLET, but none are currently priced below it.
Who manufactures SIROLIMUS 0.5 MG TABLET?
SIROLIMUS 0.5 MG TABLET (NDC 68462068201) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification